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Abstract
Psoriasin (S100A7), a member of the S100 family of calcium-binding proteins, is highly expressed in high-grade ductal
carcinoma in situ (DCIS) and in the benign hyperproliferative skin disorder psoriasis. The gene that encodes psoriasin and
many other S100 genes are located within a gene cluster on chromosome region 1q21, known as the epidermal
differentiation complex. This cluster contains genes for several differentiation markers that play important roles in the
terminal differentiation of the epidermis. The purpose of the present study was to evaluate the role of psoriasin in the
differentiation process of mammary epithelial cells. Normal mammary epithelial cells (MCF10A) cultured in confluence and
suspension, conditions known to induce psoriasin expression, demonstrated a shift towards a more differentiated
phenotype indicated by an increase in the expression of the luminal differentiation markers CD24 and MUC1 and the
reduced expression of the breast stem cell marker CD44. The expression of psoriasin and MUC1 was most pronounced in
the CD24
+-enriched fraction of confluent MCF10A cells. The shift towards a more differentiated phenotype was abolished
upon the downregulation of psoriasin using short hairpin RNA (shRNA) and small interfering RNA (siRNA). Using specific
inhibitors, we showed that psoriasin and CD24 expression was regulated by reactive oxygen species (ROS) and the nuclear
factor (NF)-kB signaling pathways. While immunohistochemical analyses of DCIS showed heterogeneity, the expression of
psoriasin and CD24 showed a similar staining pattern. Our findings suggest that the expression of psoriasin is linked to the
luminal differentiation marker CD24 in mammary epithelial cells. Psoriasin demonstrated an essential role in the shift
towards a more differentiated CD24
+ phenotype, supporting the hypothesis that psoriasin plays a role in the differentiation
of luminal mammary epithelial cells.
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Introduction
Breast tumors display a high degree of heterogeneity. Clinically,
they are divided into subtypes based on protein expression
patterns and clinical outcomes. Ductal carcinoma in situ (DCIS)
is one of the earliest forms of breast cancer and is regarded as a
precursor of invasive ductal carcinoma. High-grade DCIS is
associated with a high risk of progression to invasive breast cancer
[1].
Psoriasin (S100A7) is a member of the S100 family of calcium-
binding proteins that have been shown to be involved in the
regulation of many calcium-dependent cellular processes, such as
proliferation, apoptosis, differentiation, invasion and metastasis
[2]. Psoriasin is one of the most highly expressed genes in high-
grade DCIS [3,4]. Whereas the level is often reduced in invasive
breast carcinomas, the persistent high expression of psoriasin is
associated with markers of poor prognosis [5]. Psoriasin has been
shown to modulate tumor growth by activating several signaling
pathways. Psoriasin interacts with Jun-activating binding protein 1
(Jab1), which is involved in multiple signal transduction pathways,
including the regulation of c-Jun/AP1 transcription factors [6].
Psoriasin induces epidermal growth factor signaling [7] and
upregulates inflammatory pathways in breast cancer [8]. We and
others have demonstrated that psoriasin expression correlates with
increased survival and nuclear factor (NF)-kB signaling in
mammary epithelial cells [4,5]. Moreover, we recently showed
that psoriasin is induced by reactive oxygen species (ROS) and acts
through receptor for advanced glycation end products (RAGE) to
induce endothelial cell proliferation and angiogenesis [9].
The epidermal differentiation complex (EDC), located on
chromosome region 1q21, contains genes that play important
roles in the terminal differentiation of the human epidermis,
including psoriasin and other S100 genes [10,11]. We have
previously demonstrated that psoriasin is related to the terminal
differentiation of keratinocytes [12]. The stimulation of differen-
tiation in vitro induced the expression of psoriasin and the
differentiation marker keratin I in keratinocytes [12]. Further-
more, in a spectrum of conditions of dysregulated keratinocyte
differentiation, psoriasin expression correlated with the degree of
keratinocyte differentiation. It has been suggested that CD44
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CD24 has been identified as a molecular marker of more
differentiated luminal epithelial cells [13]. It has been shown that
CD24 is a marker of tumor aggressiveness and that the expression
of CD24 promotes breast cancer development [14,15,16].
Furthermore, both psoriasin and CD24 have been associated
with an unfavorable prognosis for patients with breast cancer
[5,6,16,17,18]. As both breast and skin epithelial cells have
ectodermal origins, the induction and functional relevance of
psoriasin may be similar in these two epithelial cell types.
Here, we demonstrate an association between psoriasin and
CD24 in mammary epithelial cells, along with a similar staining
pattern in vivo. These data support the hypothesis that psoriasin
plays a role in the differentiation of mammary epithelial cells.
Materials and Methods
Ethics statement
The study was performed under conditions approved by the
Ethics Committee at the University of Gothenburg, Gothenburg,
Sweden. Cases were selected from the archives of the Department
of Pathology, Sahlgrenska University Hospital, Gothenburg,
Sweden. The study was submitted to the local Institutional
Review board and complied with institutional guidelines. Immu-
nohistochemical stains were created from paraffin blocks in a
strictly anonymized fashion, therefore a written consent was not
mandatory. Instead, patients gave their verbal informed consent
which was documented in the referral. The consent procedure was
approved by the ethics committee.
Cell lines and culture conditions
The normal immortalized human mammary epithelial cell line,
MCF10A, was obtained from the American Type Culture
Collection (ATCC) and cultured as previously described [4].
The establishment of stable clones with downregulated psoriasin
expression was made by transfecting MCF10A with short hairpin
RNAs (shRNAs) directed against human psoriasin, as previously
described [19,20]. Transient downregulation of psoriasin expres-
sion was accomplished by transfecting MCF10A cells with small
interfering RNA (siRNA) directed against psoriasin (sc-106459,
Santa Cruz Biotechnology, Santa Cruz, USA), according to the
manufacturer’s instructions. For confluence culture, cells were
maintained in the confluent condition for 5 or 10 days. Suspension
culture was achieved by plating cells in poly-2-hydroxy-ethyl-
methacrylate (polyHEMA)-coated (10 mg/cm
2 in 95% ethanol)
Petri dishes for 3 days. Recombinant psoriasin protein (Abnova,
Taipei, Taiwan) was added to a final concentration of 2.7 mg/ml
and the cells were incubated for 48 hours. MCF10A cells in
confluence were treated, every other day for ten days, with N-
acetyl-cysteine (NAC) (10 mM), caffeic acid phenethyl ester
(CAPE) (50 mM), Tyrphostin (10 mM), U73122 (10 mM), Wort-
mannin (50 nM) and DMSO (diluents control), all purchased from
Sigma-Aldrich (St Louis, USA), or infected with dominant
negative IKK-beta (dnIKKB) adenoviral vector [21].
Magnetic activated cell sorting (MACS)
CD24
+ cells were isolated from confluence cultures, using
magnetic activated cell sorting (MACS) (Miltenyi Biotec, Auburn,
USA). A total number of 2610
7 cells were incubated with mouse
anti-human CD24 (1:20) (BD Bioscience, San Jose, USA) for
20 min at 4uC. The cells were magnetically labeled with goat anti-
mouse IgG Micro Beads and separated on an LS column and a
QuadroMACS Separator by magnetic force. Sorting was
performed according to the manufacturer’s instructions with the
following modification: PBS containing 2 mM EDTA was
supplemented with 0.5% BSA during antibody and micro bead
incubation.
Flow cytometry
The expression of CD24, CD44 and MUC1 on the cell surface
was measured by double staining using flow cytometry. A total
number of 3610
5 cells were suspended in PBS and incubated with
antibodies for 30 min at 4uC. The antibodies used were FITC-
conjugated mouse anti-human CD24 (1:20), PE-conjugated mouse
anti-human CD44 (1:50) and FITC-conjugated mouse anti-
human CD227 (MUC1) (1:30), all purchased from BD Bioscience.
Flow cytometry was performed using the FACSAria and the
results were analyzed using the FACSDiva Software v.6.1.3 (BD
Bioscience).
Western blotting
Western blotting was performed as previously described [22].
The primary antibodies that were used were the specific mouse
anti-psoriasin (IMG-409A, Imgenex, San Diego, USA) [23] and
rabbit anti-GAPDH (Santa Cruz Biotechnology, Santa Cruz,
USA). Image analysis was performed using a Fuji film LAS-1000
camera (Las1000, Image-Gauge, Fuji, Tokyo, Japan). Protein
expression was quantified using the Multi Gauge v 3.0 software.
Tissue samples
Tissue samples from 21 DCIS tumors, selected at random, were
obtained from the files of the Departments of Dermatology and
Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Blocks of formalin-fixed and paraffin-embedded tissue samples
were obtained.
Immunohistochemistry
A specific monoclonal anti-S100A7 antibody (1:200) (IMG-
409A, Imgenex) [23] and a monoclonal anti-CD24 antibody (1:50)
(MA1-19725, clone SN3) (Pierce Biotechnology, Rockford, USA)
were incubated for 25 min at room temperature. Antigen-
antibody complexes were detected by using an ABC detection
system (Vectastain Elite, P K-6102) and diaminobenzidine (DAB)
as the chromogen. All slides were evaluated by an experienced
breast pathologist (AK). Tumors were considered to be positive for
psoriasin and CD24 when neoplastic cells displayed distinct brown
nuclear, cytoplasmic or membranous staining.
Statistical analysis
Statistical significance was determined by the Student’s t-test.
Correlation analysis was performed by Spearman’s rank correla-
tion test (r). A value of p,0.05 was considered statistically
significant. The results are presented as the mean 6 standard
deviation (SD) for at least three independent experiments.
Results
Induced psoriasin expression is associated with increased
CD24 expression
To investigate the relationship between psoriasin and the
differentiation of normal mammary epithelial cells, we analyzed
the expression of CD24, a marker of differentiated luminal
epithelium, and CD44, a breast stem cell marker, in confluence-
and suspension-cultured MFC10A cells, conditions known to
induce psoriasin expression (Figure 1A). Confluence-cultured
MCF10A cells showed a progressive increase in the expression
of psoriasin and CD24, whereas the level of CD44 decreased
Psoriasin Induces CD24 Expression
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increase in the expression of psoriasin and CD24 and a decrease
in CD44 (Figure 1B). The expression of psoriasin and CD24 was
positively correlated in confluence- (Spearman’s correlation
coefficient r=0.833, p=0.005) and suspension-cultured cells
(Spearman’s correlation coefficient r=0.841, p=0.036). The
expression of MUC1, a marker of differentiated luminal epithelia,
was also increased in these culture conditions (data not shown).
These results show an increase in psoriasin expression by
confluence- and suspension-cultured MFC10A cells accompanied
by a shift towards a more differentiated CD24
+ phenotype. The
positive correlation between the expression of psoriasin and CD24
may imply a causal relationship or be the result of differentiation.
The expression of psoriasin and MUC1 is confined to
CD24
+ mammary epithelial cells
To investigate whether the expression of psoriasin and MUC1 is
enriched in CD24
+ cells, the CD24
+ fraction of confluence-
cultured MCF10A cells was separated, using magnetic cell sorting
(MACS). We demonstrated that psoriasin expression was strikingly
higher in the CD24
+ cell fraction, compared with negative
selection (Figure 2A). The expression of CD44 was reduced in the
CD24
+ cell fraction, compared with the negative selection
(Figure 2B). In addition, the expression of MUC1 was elevated
in the CD24
+ fraction to levels comparable to those of CD24
expression (Figure 2B). These results suggest that psoriasin, as well
as MUC1, is predominately expressed in CD24
+ mammary
epithelial cells.
Psoriasin and CD24 expression is regulated by ROS and
through the NF-kB pathway
Since confluence culture led to a shift towards a more
differentiated CD24
+ phenotype, we set out to identify relevant
signaling pathways involved in this process. We selected five
signaling pathways, previously shown to be involved in the
regulation of psoriasin. In confluence-cultured MCF10A cells
treated with the antioxidant NAC (Figure 3A), the expression of
psoriasin and CD24 was not induced, as compared to confluence
control. Likewise, cells treated with inhibitors of NF-kB, CAPE
(Figure 3B) and dn-IKKB (Figure 3C) did not upregulate the
expression of psoriasin and CD24. Treatment with the PLC-
inhibitor U73122 did not reduce the expression of CD24
(Figure 3D). Treatment with the EGFR-inhibitor Tyrphostin
downregulated the expression of CD24 but this effect did not
reach statistical significance (Figure 3E). The slightly reduced
psoriasin expression in response to treatment with U73122
(Figure 3 D) and Tyrphostin (Figure 3E) may also depend on
the high dose of DMSO used. MCF10A cells treated with
Wortmannin, an inhibitor of the PI3K pathway, caused no
decrease in CD24 or psoriasin expression (Figure 3F). The
inhibitors had no effect on CD44 expression, except for treatment
with NAC, which increased the expression of CD44. These
Figure 1. Confluence- and suspension-cultured mammary epithelial cells demonstrate increased psoriasin and CD24 expression.
MCF10A cells were cultured in confluence for 5 and 10 days or in suspension for 3 days. A Psoriasin expression, analyzed by Western blotting, was
induced in MCF10A cells cultured in confluence and suspension, compared with exponentially growing cells. Equal loading was confirmed by GAPDH.
The figure illustrates a representative example (n=3). B In confluence- and suspension-cultured cells, psoriasin and CD24 expression were increased,
whereas CD44 expression was decreased compared with exponentially growing cells. The expression level of CD24 and CD44 was measured using
flow cytometry and the expression level of psoriasin was quantified from Western blots. The data are presented as the mean 6 SD of relative
expression (n=3). The p-values (*,0.05, **,0.01, ***,0.001) were calculated using the Student’s t-test.
doi:10.1371/journal.pone.0053119.g001
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regulated by ROS and the NF-kB pathway.
Endogenous but not extracellular psoriasin causes
increased CD24 expression
To evaluate the role of psoriasin in the regulation of CD24 and
MUC1 expression, the endogenous expression of psoriasin in
MCF10A cells was downregulated by shRNA and siRNA. The
downregulation of psoriasin expression was confirmed in
MCF10A Pso-shRNA (Figure 4A) and Pso-siRNA (Figure 4C)
compared with C-shRNA and C-siRNA, in suspension culture.
Next, we cultured MCF10A Pso-shRNA and Pso-siRNA in
confluence or in suspension. Cells in which psoriasin upregulation
was prevented displayed a reduction in the expression of CD24,
along with an increase in the expression of CD44, compared with
C-shRNA and C-siRNA (Figure 4B and 4D). No significant
difference in MUC1 expression was observed (data not shown).
We and others have previously shown that psoriasin is secreted by
mammary epithelial cells [4,24] and may act through RAGE to
promote endothelial cell proliferation [9]. The treatment of
MCF10A cells with purified recombinant psoriasin protein did
not change the expression of CD24, CD44 and MUC1 compared
with untreated MCF10A cells (data not shown). These results
suggest that endogenously expressed psoriasin plays a crucial role
in the shift towards a CD24
+ phenotype.
Figure 2. Psoriasin and MUC1 expression is elevated in CD24
+ mammary epithelial cells. MCF10A cells were cultured in confluence for 10
days and separated for CD24
+ cells, using magnetic activated cell sorting. A Psoriasin expression, analyzed by Western blotting, was confined to the
CD24
+ cell fraction, compared with negative selection and controls. Equal loading was confirmed by GAPDH. The figure illustrates a representative
example (n=3). B Separated CD24
+ cells showed an increase in the expression of CD24 and a decrease in the expression of CD44, compared with
negative selection. The expression of MUC1 was increased in the same level as CD24 expression. The figures illustrate representative examples (n=4).
doi:10.1371/journal.pone.0053119.g002
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PLOS ONE | www.plosone.org 4 December 2012 | Volume 7 | Issue 12 | e53119Figure 3. Inhibition of ROS and the NF-kB signaling pathway suppresses psoriasin and CD24 expression. MCF10A cells were cultured in
confluence for 10 days. The inhibition of ROS using NAC (A) and NF-kB using CAPE (B) and dnIKKB (C) led to a significantly reduction in CD24 and
psoriasin expression in confluence-cultured MCF10A, measured by flow cytometry and Western blot, respectively. No reduction of CD24 expression
was seen by the inhibition of PLC-IP3 using U73122 (D). The reduced CD24 expression by Tyrphostin (E) did not reach statistical significance. The
inhibition of PI3-K by Wortmannin (F) showed no decrease in psoriasin or CD24 expression. The inhibitors showed no effect on CD44 expression,
Psoriasin Induces CD24 Expression
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pattern in DCIS breast tumors
We used immunohistochemistry to examine the expression
pattern of psoriasin and CD24 in vivo. The expression of psoriasin
and CD24 in a set of DCIS cases showed heterogeneity both
between and within samples. Psoriasin staining was observed in
the cytoplasm and the nucleus of the cells, whereas CD24 staining
was observed in the cytoplasm, the nucleus and in the in the
membranes of the mammary epithelial cells of the DCIS tumors.
Psoriasin (57.1%; 12/21) and CD24 (47.6%; 10/21) staining was
detected with a weak to strong expression in the DCIS cells.
Interestingly, psoriasin and CD24 expression showed a similar
staining pattern among the tumors. A concordant expression was
seen in 61.9% (13/21) of cases of which ten cases showed double-
positive and three cases double-negative expression. In two out of
the 21 investigated cases, normal breast tissue showed a faint
psoriasin staining. None of the analyzed cases showed positive
staining of CD24 in normal breast tissues. As demonstrated in
Figure 5, psoriasin and CD24 showed an extremely intense
staining and similar staining pattern in vivo. These findings confirm
the association between psoriasin and CD24 expression observed
in vitro.
Discussion
Psoriasin is one of the most abundantly expressed proteins in
high-grade DCIS, compared with normal mammary epithelium
and invasive breast carcinomas [4,25,26,27]. The persistent high
expression of psoriasin in invasive breast carcinoma is associated
with a poor clinical outcome [5]. We previously showed that, in
human immortalized mammary epithelial cells, MCF10A, psor-
iasin is upregulated by a loss of attachment to the extracellular
matrix and prolonged confluence [4,21,22]. Both these conditions
mimic the in vivo situation that is likely to occur in a high-grade
comedo DCIS tumor environment, suggesting a specific role for
psoriasin in the initiation of these breast tumors. The induction of
psoriasin, by conditions like suspension and confluence, has also
been observed for skin epithelial cells (keratinocytes), along with
the increased expression of the differentiation marker keratin I
[28]. In fact, well-known keratinocyte differentiation stimulators
include an increase in cell density (confluence) [29] and the
elevation of extracellular calcium [30]. Moreover, keratinocytes
cultured in suspension have also been shown to enter a
differentiation program [31]. In a previous study, we compared
the expression of psoriasin in a spectrum of conditions of
dysregulated keratinocyte differentiation. The expression correlat-
ed with the degree of keratinocyte differentiation with absent
expression in undifferentiated basalioma and strong expression in
carcinoma in situ, as well as in keratoacanthoma and differentiated
squamous cell carcinoma [28]. These immunohistochemical
except for treatment with NAC (A), which increased the expression of CD44. Western blot inserts illustrate representative examples (n=4) of the
psoriasin expression. Equal loading was confirmed by GAPDH. The data are presented as the mean 6 SD of relative expression (n=4). The p-values
(*,0.05, **,0.01, ***,0.001) were calculated using the Student’s t-test.
doi:10.1371/journal.pone.0053119.g003
Figure 4. Endogenous psoriasin causes increased CD24 expression. MCF10A cells were transfected with a psoriasin-targeting shRNA (Pso-
shRNA) or siRNA (Pso-siRNA), and their corresponding controls,(C-shRNA and C-siRNA). Transfected MCF10A cells were cultured in confluence for 10
days or in suspension for 3 days. The expression level of psoriasin was detected by Western blot. CD24 and CD44 expression were measured using
flow cytometry. A No induction of psoriasin expression was observed in Pso-shRNA, compared with C-shRNA, in confluence or suspension. B Pso-
shRNA showed a decrease in the expression of CD24 and an increase in the expression of CD44, compared with C-shRNA, during confluence and
suspension. C The expression of psoriasin in Pso-siRNA was dramatically downregulated, compared with C-siRNA. D Pso-siRNA in suspension culture
showed a reduced CD24 expression, compared with C-siRNA. Equal loading was confirmed by GAPDH. The figures illustrate representative examples
(n=3). The data are presented as the mean 6 SD of relative expression (n=3). The p-values (*,0.05) were calculated using the Student’s t-test.
doi:10.1371/journal.pone.0053119.g004
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differentiation process in different types of epithelium. In humans,
CD24 has been identified as a molecular marker that allows a
distinction to be made between differentiated luminal epithelial
and myoepithelial cells [13]. Moreover, breast cancer stem cells
are characterized by the low or negative expression of CD24 but
the high expression of CD44 [13].
We demonstrated that the suspension and confluent culturing
conditions of mammary epithelial cells induce a shift towards the
more differentiated CD24
+ phenotype, in parallel with the
endogenous induction of psoriasin. We also showed a decrease
in CD44 expression, a breast stem cell marker, and an increase in
MUC1 expression, a luminal differentiation marker. Interestingly,
we demonstrated that the degree of shifting was dependent on the
expression level of psoriasin, suggesting that the shift to a more
differentiated phenotype may be dependent on the level of
psoriasin expression. When analyzing the CD24
+ cell fraction of
confluence-cultured mammary epithelial cells, we showed that the
level of psoriasin and MUC1 was higher in this cell fraction
compared with negative selection. This supports the notion that
psoriasin is expressed in more differentiated mammary epithelial
cells.
We have previously shown that psoriasin expression is induced
by ROS and downregulated by treatment with the antioxidants
Bcl-2 and NAC [21]. We now show that psoriasin and CD24
expression are both reduced in confluence-cultured MCF10A cells
treated with the antioxidant NAC, which suggests that psoriasin
and CD24 expression is regulated by ROS. We and others have
demonstrated that psoriasin expression in mammary epithelial
cells correlates with NF-kB signaling and increased cellular
survival [21,32]. NF-kB is involved in many biological processes,
including proliferation, survival and differentiation. Accordingly,
we now show that treatment with NF-kB inhibitors downregulates
the expression of psoriasin and CD24 in confluence-cultured
MCF10A cells. Psoriasin was further shown to be induced by
epidermal growth factor signaling [7] and we demonstrate a trend
towards the downregulation of both psoriasin and CD24 by
Tyrphostin, supporting hypothesis that EGFR signaling may be
implicated in their regulation.
The role of psoriasin in the differentiation of mammary
epithelial cells was further supported by showing a reduced shift
towards the CD24
+ phenotype when downregulating psoriasin
using shRNA and siRNA. Our data suggest that induced
endogenous psoriasin expression is related to the shift towards a
CD24
+ phenotype and that psoriasin is important in the
differentiation process of mammary epithelial cells. The expression
of CD24 has been shown to be significantly higher in DCIS
compared with normal tissue [33,34]. We demonstrate a similar
staining pattern of psoriasis and CD24 in DCIS in vivo. When a
concordant expression was present, psoriasin and CD24 often
displayed extremely intense staining and similar staining pattern.
In apocrine metaplasia, the differentiation and transition of a
normal mammary epithelium to an apocrine sweat gland, we have
observed an increase in psoriasin expression [35]. The apocrine
sweat gland demonstrates an increase in the expression of CD24
and a reduction in the expression of Bcl-2 [36]. Moreover, we
have previously shown that the expression of MUC1 is weak to
moderate in normal epithelial cells and strong in DCIS, basically
corresponding to the expression of psoriasin [37]. Psoriasin and
CD24 expression in breast cancer has been associated with a poor
prognosis [5,6,16,17,18,38]. Likewise, MUC1 is frequently over-
expressed and associated with a poorer prognosis in many cancers
including breast cancer [39].
Previous studies support the role of CD24 in breast cancer
development [14]. In humans, CD24 was identified as a ligand for
P-selectin, an adhesion receptor on endothelial cells and platelets
[40]. Recently, the upregulation of VEGF-A and CD24 gene
expression by the tGLI1 (truncated glioma-associated oncogene
homolog 1) transcription factor was shown to contribute to the
aggressive behavior of breast cancer cells [41]. Interestingly, we
recently demonstrated that psoriasin induces the expression of
VEGF-A in mammary epithelial cells [9].
The terminal differentiation of mammary epithelia, which is
known as mammary gland branching morphogenesis, is partly
dependent upon interaction with the extracellular matrix (ECM)
[23]. Changes in and the dysregulation of the interactions between
epithelial cells and the ECM generate signals for pathologic
processes, such as breast tumor formation [24]. We previously
demonstrated the phospholipase C (PLC)-mediated induction of
psoriasin expression by the downregulation of the intercellular
adhesion molecule 1 (ICAM1), with important functions in
adhesion and signal transduction, supporting the hypothesis that
psoriasin plays a role in differentiation [35].
In conclusion, we show that psoriasin is linked to the putative
differentiation marker CD24 in mammary epithelial cells and that
psoriasin plays an essential role in the shift towards a more
Figure 5. Psoriasin and CD24 demonstrate a similar staining pattern in DCIS. The expression patterns of psoriasin and CD24 in ductal
carcinoma in situ (DCIS) were analyzed by immunohistochemisty. Psoriasin and CD24 showed an extremely intense staining and a similar staining
pattern in DCIS. A Psoriasin staining was observed in the cytoplasm and the nucleus of the cells. B CD24 staining was observed in the cytoplasm, the
nucleus and in the membranes of the mammary epithelial cells. The figures illustrate representative examples of psoriasin and CD24 expression in the
same DCIS tumor.
doi:10.1371/journal.pone.0053119.g005
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+ phenotype in culture conditions mimicking
the in vivo conditions seen in high-grade DCIS. Our results indicate
that psoriasin plays a role in the differentiation of mammary
epithelial cells.
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